SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-024500
Filing Date
2024-03-21
Accepted
2024-03-21 07:28:44
Documents
81
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0202038-20f_inflarx.htm   iXBRL 20-F 3080605
2 LIST OF SUBSIDIARIES ea020203801ex8-1_inflarx.htm EX-8.1 1660
3 CERTIFICATION ea020203801ex12-1_inflarx.htm EX-12.1 9604
4 CERTIFICATION ea020203801ex12-2_inflarx.htm EX-12.2 9950
5 CERTIFICATION ea020203801ex13-1_inflarx.htm EX-13.1 3864
6 CERTIFICATION ea020203801ex13-2_inflarx.htm EX-13.2 3682
7 CONSENT OF EY GMBH & CO. KG WIRTSCHAFTSPRUFUNGSGESELLSCHAFT ea020203801ex15-1_inflarx.htm EX-15.1 3668
8 CLAWBACK POLICY ea020203801ex97-1_inflarx.htm EX-97.1 29746
9 GRAPHIC image_001.jpg GRAPHIC 56645
10 GRAPHIC image_002.jpg GRAPHIC 35987
11 GRAPHIC image_003.jpg GRAPHIC 15897
12 GRAPHIC image_004.jpg GRAPHIC 43786
13 GRAPHIC image_005.jpg GRAPHIC 30383
14 GRAPHIC image_006.jpg GRAPHIC 49849
  Complete submission text file 0001213900-24-024500.txt   10334118

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE ifrx-20231231.xsd EX-101.SCH 109421
16 XBRL CALCULATION FILE ifrx-20231231_cal.xml EX-101.CAL 40248
17 XBRL DEFINITION FILE ifrx-20231231_def.xml EX-101.DEF 350342
18 XBRL LABEL FILE ifrx-20231231_lab.xml EX-101.LAB 702659
19 XBRL PRESENTATION FILE ifrx-20231231_pre.xml EX-101.PRE 365804
85 EXTRACTED XBRL INSTANCE DOCUMENT ea0202038-20f_inflarx_htm.xml XML 1350075
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38283 | Film No.: 24769429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)